SRX sierra rutile holdings limited

SRX vs BTG, page-9

  1. 41,444 Posts.
    lightbulb Created with Sketch. 1096
    MCC is current case for SRX, SRX is proven for non-standard malignant tumours at end of lives. BTG would be an interesting competitor as BTG trials would need to be successful & cost of treatment stack up against incumbent treatment IMHO.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.